Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 37,637 | 49,288 | 33,572 | 38,647 | 7,438 |
| Depreciation Amortization | 2,245 | 1,071 | 5,205 | 5,386 | 3,285 |
| Income taxes - deferred | N/A | 3,877 | N/A | 0 | N/A |
| Accounts receivable | 631 | 479 | 187 | -955 | -54 |
| Other Working Capital | 1,433 | 1,475 | -741 | -1,060 | 773 |
| Other Operating Activity | -59,107 | -64,288 | -80,549 | -75,492 | -36,001 |
| Operating Cash Flow | $-17,161 | $-8,098 | $-42,326 | $-33,474 | $-24,559 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -474 | -215 | -2,526 | -2,104 | -1,662 |
| Net Acquisitions | N/A | N/A | -8,376 | -8,376 | -8,376 |
| Other Investing Activity | -8,910 | -8,939 | 13 | 0 | 22 |
| Investing Cash Flow | $-9,384 | $-9,154 | $-10,889 | $-10,480 | $-10,016 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 299 | 123 | 1,757 | 1,150 | 1,019 |
| Debt Repayment | -31 | -31 | -145 | -104 | -74 |
| Common Stock Issued | 20,154 | 20,150 | 32,997 | 32,861 | 19,686 |
| Common Stock Repurchased | -31 | 0 | N/A | N/A | N/A |
| Other Financing Activity | 3,629 | -1,145 | -1,827 | -1,968 | -900 |
| Financing Cash Flow | $24,020 | $19,097 | $32,782 | $31,939 | $19,731 |
| Exchange Rate Effect | 87 | -117 | 292 | 237 | 317 |
| Beginning Cash Position | 22,935 | 22,935 | 42,229 | 42,229 | 42,229 |
| End Cash Position | 20,497 | 24,663 | 22,088 | 30,451 | 27,702 |
| Net Cash Flow | $-2,438 | $1,728 | $-20,141 | $-11,778 | $-14,527 |
| Free Cash Flow | |||||
| Operating Cash Flow | -17,161 | -8,098 | -42,326 | -33,474 | -24,559 |
| Capital Expenditure | -474 | -215 | -2,526 | -2,138 | -1,662 |
| Free Cash Flow | -17,635 | -8,313 | -44,852 | -35,612 | -26,221 |